Compare LINK & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LINK | XBIT |
|---|---|---|
| Founded | 1984 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Pharmaceuticals and Biotechnology |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 71.3M |
| IPO Year | 2007 | 2015 |
| Metric | LINK | XBIT |
|---|---|---|
| Price | $3.26 | $2.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | 17.1K | ★ 44.2K |
| Earning Date | 05-12-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,679,000.00 | N/A |
| Revenue This Year | $8.30 | N/A |
| Revenue Next Year | $34.68 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.76 | $2.09 |
| 52 Week High | $15.15 | $3.62 |
| Indicator | LINK | XBIT |
|---|---|---|
| Relative Strength Index (RSI) | 45.90 | 51.24 |
| Support Level | $2.84 | $2.32 |
| Resistance Level | $3.43 | $2.49 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 30.50 | 61.90 |
Interlink Electronics Inc is a sensor and printed electronics company operating in two principal sensor technology divisions: force/touch sensors, and gas and environmental sensors. It designs, develops, manufactures and sells a range of force-sensing and gas-sensing technologies that incorporate its proprietary materials technology, firmware and software into a portfolio of standard sensor-based products and custom sensor system solutions. Its force-sensing products and solutions include sensor components, subassemblies, modules products that support effective, efficient cursor control and novel three-dimensional user inputs. Its Human Machine Interface technology platforms are deployed in a wide range of markets including consumer electronics, automotive, industrial, and medical.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.